Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115633) titled 'Phase I Clinical Study of WSK-V108E in Patients with Mild to Moderate Acne Vulgaris' on Dec. 29, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital of Sichuan University
Condition:
For the treatment of acne vulgaris
Intervention:
Sentinel cohort A1-experimental group: 60µg vaccine injection on day0, day 21,day 42
Sentinel cohort A1-control group:0.25ml placebo injection on day0, day 21,day 42
Sentinel cohort B1-experimental group:120µg vaccine injection on day0, day 21,day 42
Sentinel cohort B1-control group:0.5ml placebo injection on day0, day 21...